Xinjiang Huashidan Pharmaceutical

Xinjiang Huashidan Pharmaceutical is a prominent pharmaceutical manufacturer based in Urumqi, Xinjiang, China. Established in 1993, the company has developed a robust portfolio that integrates Traditional Chinese Medicine (TCM) with modern chemical pharmaceuticals. It is widely recognized for its flagship product, Compound Yizhihao, which serves as a leading treatment for the common cold and influenza in the region. The company operates multiple GMP-certified production lines and maintains a significant presence in the respiratory and cardiovascular therapeutic markets. Additionally, Huashidan is known for its research into high-altitude medicine, producing specialized treatments like Compound Rhodiola. The firm continues to leverage regional botanical resources to expand its natural medicine offerings.